Tci Wealth Advisors, Inc. Sarepta Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$117.53 - $155.99 $17,747 - $23,554	-151 Reduced 98.69%	2 $0
Q4 2022 Feb 06, 2023	BUY	$100.86 - $132.13 $15,431 - $20,215	153 New	153 $19,000
Q2 2022 Jul 19, 2022	SELL	$62.69 - $88.44 $6,080 - $8,578	-97 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$65.97 - $92.48 $131 - $184	2 Added 2.11%	97 $9,000
Q2 2021 Aug 02, 2021	BUY	$69.38 - $86.75 $6,313 - $7,894	91 Added 2275.0%	95 $7,000
Q1 2021 Apr 29, 2021	SELL	$72.25 - $168.95 $7,225 - $16,895	-100 Reduced 96.15%	4 $0
Q1 2020 Apr 14, 2020	BUY	$82.38 - $131.64 $329 - $526	4 Added 4.0%	104 $10,000
Q4 2019 Jan 27, 2020	BUY	$76.53 - $135.58 $7,653 - $13,558	100 New	100 $13,000
Q2 2019 Jul 23, 2019	SELL	$112.21 - $151.95 $336 - $455	-3 Closed	0 $0
Q1 2019 Apr 11, 2019	BUY	$106.67 - $151.68 $320 - $455	3 New	3 $0
Q4 2018 Jan 17, 2019	SELL	$97.32 - $148.76 $1,070 - $1,636	-11 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$115.31 - $161.51 $1,268 - $1,776	11 New	11 $2,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.9B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.